Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review.

Long Q, Smith H, Zhang T, Tang S, Garner P.

BMC Public Health. 2011 May 26;11:393. doi: 10.1186/1471-2458-11-393. Review.

2.

Patient adherence to tuberculosis treatment: a systematic review of qualitative research.

Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J.

PLoS Med. 2007 Jul 24;4(7):e238. Review.

3.

Are free anti-tuberculosis drugs enough? An empirical study from three cities in China.

Chen S, Zhang H, Pan Y, Long Q, Xiang L, Yao L, Lucas H.

Infect Dis Poverty. 2015 Oct 28;4:47. doi: 10.1186/s40249-015-0080-y.

4.

Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K.

Eur Respir J. 2014 Jun;43(6):1763-75. doi: 10.1183/09031936.00193413. Epub 2014 Feb 13. Review.

5.

Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.

Pan HQ, Bele S, Feng Y, Qiu SS, Lü JQ, Tang SW, Shen HB, Wang JM, Zhu LM.

Int J Tuberc Lung Dis. 2013 Dec;17(12):1575-80. doi: 10.5588/ijtld.13.0144.

PMID:
24200271
6.

Pharmaceutical policies: effects of financial incentives for prescribers.

Rashidian A, Omidvari AH, Vali Y, Sturm H, Oxman AD.

Cochrane Database Syst Rev. 2015 Aug 4;(8):CD006731. doi: 10.1002/14651858.CD006731.pub2. Review.

PMID:
26239041
7.

Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study.

Liu Q, Smith H, Wang Y, Tang S, Wang Q, Garner P.

Trop Med Int Health. 2010 Jan;15(1):26-32. doi: 10.1111/j.1365-3156.2009.02427.x. Epub 2009 Nov 16.

8.

Non-medical financial burden in tuberculosis care: a cross-sectional survey in rural China.

Li Q, Jiang W, Wang Q, Shen Y, Gao J, Sato KD, Long Q, Lucas H.

Infect Dis Poverty. 2016 Jan 26;5:5. doi: 10.1186/s40249-016-0101-5.

9.

How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.

Liu X, Thomson R, Gong Y, Zhao F, Squire SB, Tolhurst R, Zhao X, Yan F, Tang S.

Trop Med Int Health. 2007 Dec;12(12):1464-71.

10.

Economic impact of tuberculosis at the household level.

Kamolratanakul P, Sawert H, Kongsin S, Lertmaharit S, Sriwongsa J, Na-Songkhla S, Wangmane S, Jittimanee S, Payanandana V.

Int J Tuberc Lung Dis. 1999 Jul;3(7):596-602.

PMID:
10423222
11.

Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study.

Lei X, Huang K, Liu Q, Jie YF, Tang SL.

Infect Dis Poverty. 2016 May 5;5:38. doi: 10.1186/s40249-016-0134-9.

12.

The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria.

Ukwaja KN, Alobu I, Lgwenyi C, Hopewell PC.

PLoS One. 2013 Aug 27;8(8):e73134. doi: 10.1371/journal.pone.0073134. eCollection 2013.

13.

[Tuberculosis in Asia].

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID:
12440145
14.

The economic burden of TB diagnosis and treatment in South Africa.

Foster N, Vassall A, Cleary S, Cunnama L, Churchyard G, Sinanovic E.

Soc Sci Med. 2015 Apr;130:42-50. doi: 10.1016/j.socscimed.2015.01.046. Epub 2015 Jan 27.

15.

The economic burden of tuberculosis care for patients and households in Africa: a systematic review.

Ukwaja KN, Modebe O, Igwenyi C, Alobu I.

Int J Tuberc Lung Dis. 2012 Jun;16(6):733-9. doi: 10.5588/ijtld.11.0193. Epub 2012 Mar 8. Review.

PMID:
22410546
16.

Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China.

Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, Fang XH, Pan HF.

BMC Health Serv Res. 2011 Dec 16;11:341. doi: 10.1186/1472-6963-11-341.

17.
18.

Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe.

Kemp JR, Mann G, Simwaka BN, Salaniponi FM, Squire SB.

Bull World Health Organ. 2007 Aug;85(8):580-5.

19.

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

Acosta A, Ciapponi A, Aaserud M, Vietto V, Austvoll-Dahlgren A, Kösters JP, Vacca C, Machado M, Diaz Ayala DH, Oxman AD.

Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005979. doi: 10.1002/14651858.CD005979.pub2. Review.

PMID:
25318966
20.

Quality of tuberculosis care and its association with patient adherence to treatment in eight Ethiopian districts.

Mesfin MM, Newell JN, Walley JD, Gessessew A, Tesfaye T, Lemma F, Madeley RJ.

Health Policy Plan. 2009 Nov;24(6):457-66. doi: 10.1093/heapol/czp030. Epub 2009 Aug 3.

PMID:
19651709

Supplemental Content

Support Center